Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.82 |
| ▸ | MAPT | P10636 | 3/20 | 0.82 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.82 |
| ▸ | LMNA | P02545 | 2/20 | 0.82 |
| ▸ | TSHR | P16473 | 2/20 | 0.82 |
| ▸ | BLM | P54132 | 2/20 | 0.82 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.82 |
| ▸ | MEN1 | O00255 | 2/20 | 0.82 |
| ▸ | MPO | P05164 | 1/20 | 0.82 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.82 |
| ▸ | APAF1 | O14727 | 1/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | RECQL | P46063 | 1/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | HTR2A | P28223 | 3/20 | 0.59 |
| ▸ | HTR1A | P08908 | 2/20 | 0.59 |
| ▸ | HTR2C | P28335 | 2/20 | 0.59 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.59 |
| ▸ | HTR7 | P34969 | 2/20 | 0.59 |
| ▸ | HTR2B | P41595 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tryptophan SCHEMBL2005670 | 1.00 | KDM4E (0.82) | KDM4EMAPTKMT2ALMNATSHR | |
| Dl-Tryptophan SCHEMBL2143522 | 1.00 | KDM4E (0.82) | KDM4EMAPTKMT2ALMNATSHR | |
| Dl-Tryptophan SCHEMBL28171407 | 0.95 | KDM4E (0.74) | KDM4EMAPTKMT2ALMNATSHR | |
| Dl-Tryptophan SCHEMBL28790481 | 0.95 | KDM4E (0.74) | KDM4EMAPTKMT2ALMNATSHR | |
| Tryptophan SCHEMBL6863186 | 0.95 | KDM4E (0.74) | KDM4EMAPTKMT2ALMNATSHR | |
| Dl-Tryptophan SCHEMBL27301798 | 0.95 | KDM4E (0.74) | KDM4EMAPTKMT2ALMNATSHR | |
| Dl-Tryptophan SCHEMBL28081358 | 0.94 | KDM4E (0.73) | KDM4EMAPTKMT2ALMNATSHR | |
| Dl-Tryptophan SCHEMBL28831866 | 0.93 | KDM4E (0.71) | KDM4EMAPTKMT2ALMNATSHR | |
| Tryptophan SCHEMBL17503874 | 0.93 | KDM4E (0.71) | KDM4EMAPTKMT2ALMNATSHR | |
| Dl-Tryptophan SCHEMBL29253127 | 0.93 | KDM4E (0.71) | KDM4EMAPTKMT2ALMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120136973-A | Multifunctional cyclic peptide and application thereof | 山东第二医科大学 | 2025-06-13 | — | — | CN | claimed |
| WO-2024181785-A1 | SUSTAINED RELEASE PARTICLES CONTAINING OLIGOPEPTIDES AND METHOD FOR PRODUCING SAME | 주식회사 포스테라헬스사이언스 | 2024-09-06 | — | — | WO | claimed |
| CN-110483618-B | Hetero [4] arene derivatives, their preparation and use | 青岛科技大学 | 2022-09-09 | — | — | CN | claimed |
| US-20220162558-A1 | METHOD FOR INDUCING DIFFERENTIATION OF STEM CELLS INTO CHONDROCYTES BY USING OLIGOPEPTIDES | POSTERA HEALTH SCIENCE Inc. (KR) | 2022-05-26 | — | — | US | claimed |
| CN-110483618-A | Miscellaneous [4] arene derivatives and its preparation and application | UNIV QINGDAO SCIENCE & TECHNOLOGY | 2019-11-22 | — | — | CN | claimed |
| EP-3544992-A1 | G-PROTEIN-COUPLED RECEPTOR INTERNAL SENSORS | The Regents of The University of California (US) | 2019-10-02 | — | — | EP | claimed |
| WO-2018098262-A1 | G-PROTEIN-COUPLED RECEPTOR INTERNAL SENSORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-05-31 | — | — | WO | claimed |
| US-9164106-B2 | Determination of decreased metabolism of tryptophan in diagnosis of autism spectrum disorders | GREENWOOD GENETIC CENTER, INC. (US) | 2015-10-20 | — | — | US | claimed |
| US-20130244273-A1 | Determination of Decreased Metabolism of Tryptophan in Diagnosis of Autism Spectrum Disorders | GREENWOOD GENETIC CENTER, INC. (US) | 2013-09-19 | — | — | US | claimed |
| EP-1642910-B1 | Rationally designed antibodies | ALEXION PHARMA INC (US) | 2012-02-08 | — | — | EP | claimed |
| US-7482435-B2 | Immunoglobulin for use in human therapeutics and diagnostics | ALEXION PHARMACEUTICALS, INC. (US) | 2009-01-27 | — | — | US | claimed |
| EP-1589034-B1 | Rationally designed antibodies | ALEXION PHARMA INC (US) | 2008-11-19 | — | — | EP | claimed |
| EP-1642910-A1 | Rationally designed antibodies | ALEXION PHARMACEUTICALS, INC. (US) | 2006-04-05 | — | — | EP | claimed |
| EP-1370589-B1 | RATIONALLY DESIGNED ANTIBODIES | ALEXION PHARMA INC (US) | 2006-03-15 | — | — | EP | claimed |
| EP-1589034-A2 | Rationally designed antibodies | ALEXION PHARMACEUTICALS, INC. (US) | 2005-10-26 | — | — | EP | claimed |
| EP-1370589-A2 | RATIONALLY DESIGNED ANTIBODIES | ALEXION PHARMACEUTICALS, INC. (US) | 2003-12-17 | — | — | EP | claimed |
| US-20030049683-A1 | Immunoglobulin for use in human therapeutics and diagnostics | ALEXION PHARMACEUTICAL, INC. | 2003-03-13 | — | — | US | claimed |
| WO-2002046238-A2 | RATIONALLY DESIGNED ANTIBODIES | ALEXION PHARMACEUTICALS, INC. (US) | 2002-06-13 | — | — | WO | claimed |
| EP-4653419-A1 | LINKER FOR ANTIBODY-DRUG CONJUGATES, AND ANTIBODY-DRUG CONJUGATE | Otsuka Pharmaceutical Co., Ltd. (JP) | 2025-11-26 | — | — | EP | disclosed |
| US-4104123-A | GROWTH MEDIUM CONTAINING CERTAIN AMINO ACIDS | LES PRODUITS ORGANIQUES DU SANTERRE ORSAN (FR) | 1978-08-01 | — | — | US | disclosed |